Perindopril for improving cardiovascular events.
作者信息
DiNicolantonio James J, O'Keefe James H
机构信息
Department of Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
出版信息
Vasc Health Risk Manag. 2014 Aug 30;10:539-48. doi: 10.2147/VHRM.S68384. eCollection 2014.
Abstract
摘要
相似文献
1
Perindopril for improving cardiovascular events.培哚普利用于改善心血管事件。
Vasc Health Risk Manag. 2014 Aug 30;10:539-48. doi: 10.2147/VHRM.S68384. eCollection 2014.
2
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.替米沙坦与培哚普利降压及心血管获益的比较性综述
Vasc Health Risk Manag. 2014 Apr 5;10:189-200. doi: 10.2147/VHRM.S59429. eCollection 2014.
3
[Therapy of hypertension. Also pulse pressure must be reduced].
MMW Fortschr Med. 2003 Sep 11;145(37):65.
4
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?替米沙坦与ONTARGET试验中的卒中减少：降压之外的获益？
Cerebrovasc Dis. 2008;26(5):563-4. doi: 10.1159/000164555. Epub 2008 Oct 21.
5
6
[Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
MMW Fortschr Med. 2007 Dec 6;149(49-50):52-3.
7
A quest--halting the progression of autosomal dominant polycystic kidney disease.一项探索——阻止常染色体显性多囊肾病的进展。
N Engl J Med. 2014 Dec 11;371(24):2329-31. doi: 10.1056/NEJMe1412586. Epub 2014 Nov 15.
8
Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension.血管紧张素受体阻滞剂（ARB）或血管紧张素转换酶抑制剂（ACEI）给药对高血压患者血浆醛固酮和脂联素水平的影响
Int Heart J. 2009 Jul;50(4):501-12. doi: 10.1536/ihj.50.501.
9
Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.替米沙坦与血管紧张素转换酶抑制剂治疗高血压的比较：随机对照试验的荟萃分析
J Hum Hypertens. 2009 May;23(5):339-49. doi: 10.1038/jhh.2008.132. Epub 2008 Nov 6.
10
[Observational study of an AT1-antagonist].[一种血管紧张素Ⅱ1型受体拮抗剂的观察性研究]
MMW Fortschr Med. 2007 Aug 16;149(33-34):37. doi: 10.1007/BF03365120.
引用本文的文献
1
Handling of Ventricular Fibrillation in the Emergency Setting.急诊环境下心室颤动的处理
Front Pharmacol. 2020 Jan 29;10:1640. doi: 10.3389/fphar.2019.01640. eCollection 2019.
本文引用的文献
1
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.替米沙坦与培哚普利降压及心血管获益的比较性综述
Vasc Health Risk Manag. 2014 Apr 5;10:189-200. doi: 10.2147/VHRM.S59429. eCollection 2014.
2
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂对糖尿病患者全因死亡率、心血管死亡和心血管事件的影响：荟萃分析。
JAMA Intern Med. 2014 May;174(5):773-85. doi: 10.1001/jamainternmed.2014.348.
3
4
Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis.通过动态血压监测评估血管紧张素受体阻滞剂作为单一疗法的降压疗效：一项荟萃分析。
Eur Heart J. 2014 Jul;35(26):1732-42. doi: 10.1093/eurheartj/eht333. Epub 2013 Aug 21.
5
Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.并非所有血管紧张素转换酶抑制剂都一样：关注雷米普利和培哚普利。
Postgrad Med. 2013 Jul;125(4):154-68. doi: 10.3810/pgm.2013.07.2687.
6
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
7
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.培哚普利、依那普利、氯沙坦和替米沙坦治疗超重或肥胖高血压患者的随机试验。
Clin Drug Investig. 2013 Aug;33(8):553-61. doi: 10.1007/s40261-013-0094-9.
8
A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.临床应用的血管紧张素 II 型 1 受体拮抗剂的特性的系统比较。
Pharmacol Rev. 2013 Mar 13;65(2):809-48. doi: 10.1124/pr.112.007278. Print 2013 Apr.
9
Trends in Prescription and Determinants of Persistence to Antihypertensive Therapy : The PAPEETE Study.抗高血压治疗的处方趋势及持续用药的决定因素：帕皮提研究
High Blood Press Cardiovasc Prev. 2009 Dec;16(4):167-76. doi: 10.2165/11530410-000000000-00000. Epub 2013 Jan 3.
10
Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome.拉丁美洲 2 型糖尿病和代谢综合征患者高血压共识。
J Hypertens. 2013 Feb;31(2):223-38. doi: 10.1097/HJH.0b013e32835c5444.
Zotero 插件